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Chapter 1: 
Troponin and its Role in Muscle 
Contraction 
 
  
4 
 
 
Muscle contraction is one of the most basic aspects of human life. It controls 
essentially all types of movement of or within the body. The muscles of the heart 
contract and send their nutrient-rich cargo to the farthest reaches of the body. The 
diaphragm rises and falls, allowing air to rush in and out of the lungs. And of course, the 
skeletal muscles pull on nearly every bone in the body, somehow creating the fluid 
motions that our bodies make every day.  
Being so crucial to advanced life, it has also been a significant topic of study for 
researchers. The study of skeletal muscle contraction in particular, has been extensive, 
both its physiology and its biochemistry1. The skeletal muscle unit of contraction, the 
sarcomere, is composed of two filamentous chains of proteins, one thin and one thick, 
as shown in Figure 1.1 Upon signaling from the nervous system, the myosin chains pull 
the actin chains towards their center. The increased overlap of the two fibers leads to an 
overall shortening of the muscle fiber, resulting in contraction2. 
At the microscopic level, this process is fairly intricate. Myosin “heads”- globular 
domains protruding from the protein chain- bind to specific sites on the actin molecules. 
Upon binding, these heads undergo a “flexing” motion: the length of protein connecting 
the head to the main protein body bends, pulling the actin chain along with it, utilizing 
the release of a free phosphate from hydrolyzed ATP3. The subsequent binding of a 
new ATP molecule allows the myosin head to release from its binding site on the actin 
chain and resume its original position to allow for binding of another site3. 
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Figure 1: A) Model of the sarcomere, the 
fundamental unit of contraction in skeletal muscle B) 
Model of the actin-tropomyosin-troponin complex in 
the relaxed position C) Model of the complex during 
contraction1 
 
Obviously, this process must be highly regulated. Since skeletal muscles work in 
pairs3, the body must be able to activate and deactivate contraction relatively quickly to 
allow for fluid movements. In skeletal muscles, this regulation is achieved through use 
of the troponin-tropomyosin complex4. The binding sites on actin are blocked by 
tropomyosin under normal conditions. Without access to these sites, myosin cannot 
move the thin filament and contract the muscle fiber5.  
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Troponin complex: Structure 
The troponin complex consists of three distinct subunits. Troponin T (TnT) serves 
a primarily structural purpose 1, binding to tropomyosin as well as the other subunits of 
troponin to affix the protein and form the troponin-tropomyosin complex. Troponin I (TnI) 
is the inhibitory unit of troponin, and it inhibits the ATPase activity of the actomyosin 
complex in a Ca2+-independent manner6. The binding of this subunit to actin is 
significantly increased by the presence of tropomyosin, as is its inhibitory activity7. While 
these subunits are vital to the overall contractile activity of skeletal muscle, they are of 
only secondary concern in this investigation.  
The primary focus of this study is troponin C (TnC), the regulatory calcium-
binding subunit of the complex1. TnC contains two globular domains connected by a 
long helix8.  Each domain is composed of two helix-loop-helix EF hand motifs, each of 
which contains a calcium-binding site in the loop. The C-terminal domain contains sites 
that bind calcium with relatively high affinity, but these loops also bind magnesium, 
which will occupy the sites under physiological conditions due to its greater 
concentration in muscle cells4, 7, 9. The N-terminal domain, on the other hand, has sites 
that bind with much lower affinity, but increased specificity. This makes the domain 
much more effective for regulatory purposes than the C-terminal domain, whose 
function is primarily structural10, 11. 
Troponin C and the calcium switch 
 Intake of calcium into the muscle cell induces the contraction event within the 
sarcomere2. In a model first proposed by Herzberg et al.12, calcium binding causes the 
N-terminal domain of TnC to adopt a conformation that exposes a normally-buried 
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hydrophobic patch. Various site directed mutant TnC proteins designed to stabilize or 
destabilize the apo or calcium-bound forms seem to support this model, demonstrating 
that limiting the molecule’s ability to adopt different conformations affected both its 
calcium affinity and its regulatory activity13-15 
 This activity is responsible for removing the previously mentioned inhibition of the 
actomyosin activity by TnI16. These two subunits bind together at a number of sites9, 
and their affinity is significantly increased in the presence of calcium, though it is not 
entirely removed in its absence17. It follows that the removal of inhibition is related to 
this change in binding rather than a total dissociation of the two subunits.  
 Given this change in TnC-TnI binding, as well as TnI’s binding and inhibition of 
actomyosin activity, it seems that TnI movement acts as a physical switch that allows 
activation and deactivation of muscle contraction18. This switch in conformation leads to 
a shift in the tropomyosin conformation, exposing the myosin-binding sites on actin and 
allowing the contractile activity of myosin to begin5. 
 The initial step—calcium binding and the subsequent conformational shift in the 
N-terminal region of troponin C—is the primary focus of this investigation. The purely 
structural nature of this particular mechanism makes it an ideal candidate for 
computational studies. Given the C-terminal region’s lack of regulatory function and the 
computational load of larger molecules, only the N-terminal region of troponin C is 
utilized in the research methods that will be detailed in Chapters 2 and 3. 
Computational Research 
 This study is not the first time that computation has been used in the study of 
troponin activity. A number of publications have utilized simulations of troponin in 
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various conditions to elucidate information about the mechanics of this opening action, 
both in skeletal and cardiac troponin. Lindert et al. demonstrated that cardiac troponin, 
which does not open to the same fully open conformation as its skeletal counterpart on 
its own, without the presence of TnI19, in fact undergoes an increase in the variability of 
structure, indicating a dynamics-based mechanism of troponin C opening rather than an 
absolute structural shift. 20, 21 Genchev et al. utilized a computational simulation to 
demonstrate similar, though not identical results using skeletal troponin, showing that 
without TnI, skeletal troponin quickly closed to a semi-open state rather than its full 
open conformation22. Building off of these computational studies is the primary focus of 
this investigation. While structural studies indicate a direct conformational change 
between closed and open states and exposure of the hydrophobic patch buried in 
troponin23, studies like those performed by Genchev et al. suggest that this may not be 
the case, and instead suggest the possibility of a dynamics-based change like that 
which was found in cardiac troponin21, 22. 
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Chapter 2: 
Full Model Creation Using the 
Rosetta Suite 
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Rosetta CM 
 The number of fully solved protein structures is always growing. The Protein 
Databank currently contains over 120,000 different macromolecular structures24. 
However, there are still a vast number of structures that remain unsolved. For these 
gaps in scientific knowledge, it can be useful to utilize computational substitutes for 
experimental data. Rosetta is a full suite of software designed for the purpose of 
macromolecular modelling, from de novo structure determination to protein-protein 
docking. The Rosetta library includes a number of protocols written to most effectively 
utilize the power of the Rosetta software, and two are of particular significance in this 
project. The RosettaCM protocol is used for comparative modelling of protein 
structures25, while the RosettaLigand protocol is used for docking small ligands to 
binding sites within a protein26.  
 Comparative modelling is a method of structure determination that uses protein 
structures that have already been determined as the basis for creating a structure for a 
protein for which no model exists. While programs such as NAMD are almost entirely 
theoretical, utilizing only a series of algorithms to determine movement once the initial 
structures are provided, RosettaCM includes a knowledge-based approach. Previous 
experimental data is utilized extensively throughout the process in a number of ways. 
The general process for forming the model of a new protein is outlined below, as well as 
in Figure 225. 
Concepts and Implementation 
Template threading 
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 The process begins with at least one template protein structure (in .pdb format) 
and the desired protein sequence. The target sequence and template sequences are 
aligned to match residues that are either identical or similar among multiple sequences. 
Once the alignment has been generated, the threading process can begin. A model of 
the target sequence is generated, and sections that are identical or similar are aligned 
in space so that backbone structure is conserved as much as possible, as shown in 
Figure 225.  
 
Figure 2: (L) A flowchart detailing the process of forming a protein model through 
comparative modelling (R) Illustrations demonstrating the methods described in the 
process25 
 
Full model assembly 
This threading process creates one model for each template provided, and while these 
models are very close to the template, they do not take into account the differences 
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between template and target, and they must also be combined into a single structure for 
use in molecular simulations. To accomplish this, Rosetta first splits each of the models 
into fragments (partial threads). This is done primarily by preserving secondary structure 
elements (helices and beta sheets) as whole segments, with loop regions between 
elements being split in half and combined with the attached secondary structures. This 
essentially leaves a pool of fragments from the various templates that can be 
recombined to build the full structure. To supplement this recombination, the sequence 
is also used to generate fragment files. A program known as Robetta is used to take the 
various amino acid combinations in segments of 3 and 9 residues and searches across 
known protein models for identical fragments27. From there, the torsion (phi psi) angles 
are determined for each known fragment.  
 Once all fragments have been assembled, Rosetta begins assembling various 
full models using a combination of template fragments and de novo fragments 
generated by Rosetta using the fragment torsion angles. This process is repeated 
several times utilizing a different series of fragments each time to assemble a set of 
models (1,000-10,000 different models)25. These models are then assigned a score 
using RosettaCM’s built-in score function, which weighs a number of factors to 
determine what it believes to be the “best” model28. The score function utilizes the 
differences between the target structure and the templates (using RMSD values) across 
aligned regions, as well as the overall energy of the atoms present in the structure, to 
select the most optimal structure28. 
 Structures at this state often have correct topology, but are often severely 
distorted internally, particularly at loop regions. Since each loop is split in half, with each 
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side being affixed to its corresponding secondary structure, the loop regions are often 
disconnected in space, as seen in figure 2D. To remedy this, Rosetta CM replaces 
these two loop fragments and superimposes a de novo fragment from the fragment 
pool. This fragment is then smoothed with a local energy gradient minimization step. 
The models at this stage are nearly complete. All that remains is to explicitly represent 
the side chains, which had been approximated up to this point using the Rosetta 
centroid functions, and optimize their orientation in space.  
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Methods 
There is no existing experimental structure for human skeletal troponin C. To 
assemble a reliable model for human skeletal troponin, a total of four separate 
templates were used. Each of these models was taken from the Protein Databank. The 
structures for apo skeletal troponin from Gallus gallus (domesticated chicken)23 and 
Melleagris gallopavo (domesticated turkey)29 were used as templates for the apo form. 
The calcium bound model was formed using structures of calcium-bound troponin from 
Gallus gallus23, as well as that of Oryctolagus cuniculus(European rabbit)30.  
First, a basic alignment of amino acid sequence was performed to align each of 
these models with tnnc231, the translated amino acid sequence of human troponin C. 
Alignment was performed using the Basic Local Alignment Search Tool (BLAST)32. As 
can be seen in Figure 3, the alignments are very strong, with differences primarily 
existing in the terminal and loop regions, and % identity values greater than 95%. These 
alignment files, along with the PDB files of the six models, were fed into the Rosetta 
software and the 1tnnc2 sequence was threaded into the basic shape of these models, 
yielding two sets of two models of human troponin.  
1tnnc2 --MTDQQAEARSYLSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDA 
1trf   -----------AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMK--- 
1tnp   ASMTDQQAEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDA 
1tcf   ---TDQQAEARSYLSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDA 
 
Figure 3: Alignment of the 1tnnc2 sequence to 1TNP, 1TRF, and 1TCF23, 29, 30, 32 
 
The sequence was also fed into the website Robetta28, which used its knowledge 
databank to generate a list of fragment angles. One list contained all known angles for 
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three amino acid-length fragments that matched the given sequence, and another that 
did the same for fragments that were nine amino acids long.  
These models were then run through the “Hybridize” protocol28 (see steps 1 and 
2 from Figure 2), which combined parts of the two models with segments from the 
fragment files to form a series of full hybrid models. A total of 1000 models were 
generated, each with a unique combination of threaded model and de novo fragments. 
These models were scored using RosettaCM scoring function, and the best scoring 
model was selected for the next step. 
To this point, the processes for the apo and Ca2+-bound versions have been 
largely identical, with the exception of the base models used. However, an additional 
step was necessary to account for one significant difference: the presence of the 
calcium ions. While the Rosetta CM documentation claims that it can integrate simple 
ligands and ions 25, all attempts at doing so through the original protocol were 
unsuccessful. Instead, a different Rosetta protocol was used: RosettaLigand docking. 
RosettaLigand is a docking protocol for docking small molecules into protein binding 
sites26. RosettaLigand utilizes a stochastic procedure combined with simple energy 
minimization of side chains to determine a series of possible binding locations within a 
given protein structure26. 20 different combinations of calcium and side chain placement 
were generated for each binding site. By aligning these calcium-binding loops with 
experimentally determined structures in Chimera visualization software33, the best 
binding site was determined, primarily through visual analysis of the placement of 
nearby acidic residues that were likely vital in coordinating the positively-charged 
calcium. 
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Once the calcium was docked into the newly generated human troponin models, 
both it and the apo form could be completed. The final “Relax” protocol 25 was 
performed on both forms, generating 100 models that were primarily concerned with full 
side chain optimization. These models were clustered based on their RMSD, and the 
lowest score from the largest cluster was selected, yielding the two final models.  
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Results and Discussion 
 The final models can be seen in Figure 4. The interhelical angle between 
helices A and B is shown, which will be relevant in the analysis of later simulations. 
Additionally, a visualization of the hydrophobic patch in both forms is also shown. The 
increased exposure of the hydrophobic residues is clearly evident in this visualization. 
Comparative modelling and de novo protein structure prediction are still relatively 
young fields, and many still widely prefer more traditional experimental methods for 
structural discovery. This particular case was an ideal one, with multiple proteins with 
largely identical function across species as well as highly similar sequence identity 
being used as templates. However, the value of such software should not be 
underestimated. The program was able to construct a new protein model utilizing a 
sequence for which no such model existed, demonstrating the increasing ability of 
computational biochemistry 
While this software is incredibly powerful and capable of far more than was 
asked of it in this case, comparative modelling was not the focus of this particular 
project. The construction of these full human skeletal troponin C models was simply the 
first preparatory step in the analysis of the dynamics associated with its activity. 
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A. 
 
 
Fig 4a: Models of apo and calcium-bound Rosetta models, from L to R, with A-B 
interhelical angles indicated 
 
 
 
 
 
4b: Van Der Waals visualization of the hydrophobic patch of the Rosetta model with 
apo on the left and calcium-bound on the right. Blue indicates positively charged 
residues, red indicates negatively charged residues, green indicates polar residues, 
and white indicates hydrophobic residues 
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Chapter 3: 
Molecular Simulation of Troponin 
C with NAMD 
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NAMD: Concepts and Application 
 Due to the incredibly small scale of troponin C shifts, both in space and time, 
computational simulations are an ideal tool for studying this its mechanism. There are a 
number of different programs designed for such problems, each with their own method 
of effectively modeling the various interactions present with proteins contained within 
cellular conditions. NAnoscale Molecular Dynamics (NAMD) represents one of the most 
prominent and well-known of these programs34. 
 NAMD allows for simulations of relatively large systems (>100,000 atoms) using 
the Newtonian equation of motion shown in Figure 5, which is used to calculate the 
motion of each individual atom within the simulation.  
 
 
Figure 5: The Newtonian equation of motion utilized by NAMD to simulate the motion 
of each individual atom34. 
 
The potential energy for each atom, represented here as Utotal, is itself comprised of five 
separate terms that correspond to the energies associated with inter atomic forces. 
Three terms determine the energy of bonded atoms: bond stretching, bond angle, and 
bond torsion (dihedral angles); while the other two cover the Van der Waal’s forces and 
electric (Coulomb) forces between non-bonded atoms in space.34  
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Limitations and Solutions 
Simulations for cellular conditions, while relatively large, cover only a small space 
compared to that of an actual biological cell. If simulations were allowed to continue with 
no restrictions on the boundary of the system, then the molecules would invariably 
spread out over time as the intermolecular forces drive them apart. It also means that 
less force will be applied to atoms on the boundary, which limits the applicability of 
these simulations to real-life events. To account for this, NAMD utilizes periodic 
boundary conditions. This concept treats the simulation as an infinitely-repeating series 
of identical systems that perfectly mirror the activity of the original, extending in all 
directions. When an atom crosses the boundary, an identical copy of this atom is then 
inserted into the opposite side of the system. Since the system repeats, the atom 
experiences the same forces when it crosses the boundary as it did before crossing. So 
long as the boundary leaves enough room for individual copies of the protein to come 
into contact with one another, the simulation can appropriately mimic the normal cellular 
conditions.   
 While the periodic boundary solves the issue of behavior at the edge of the 
simulation, it introduces another problem. The force experienced by each atom in the 
system is dependent on the forces exerted upon it by every other atom in the simulation 
to which it is not bonded. This concept, in combination with the infinitely repeating 
periodic system, makes calculation of Coulomb forces and Van der Waals forces 
computationally unviable over any useful time-scale. To effectively balance efficiency 
with accuracy for these simulations, two separate modifications are made to the 
calculation of Coulomb forces. 
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 The first is a simple cut-off distance that can be set by the user for each 
simulation. Atoms more than a certain distance apart from each other are ignored in 
Van der Waals force calculations34. Since the force is inversely proportional to the 
square of the distance between the two atoms, at longer distances the force becomes 
so small as to be negligent in calculations. This helps mitigate the effects of the 
infinitely-repeating boundary, but force calculation remains non-trivial in systems with 
tens or hundreds of thousands of atoms. To optimize electrostatic computations, NAMD 
uses the periodic conditions along with the particle-mesh Ewald (PME) method to 
compute the full electrostatic potential for the system35, 36. 
 The PME method utilizes a three-dimensional mesh overlaying the entire system. 
For each particle in the system, the charge is distributed over the grid points 
surrounding it, with weights assigned to each gridpoint relative to the distance from the 
actual point of charge (see Fig. 6)34. The full algorithms that are utilized for these 
calculations are relatively complex and beyond the scope of this project, but this method 
allows for the computation of the full electrostatic potential across the whole system 
using the periodic boundary conditions while still remaining feasible for nanosecond-
scale simulations. 
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Figure 6. Left: 2-dimensional representation of the particle-mesh Ewald method, with 
charge q distributed across mesh points according to the distance to the charge. Right: A 
smoothed model of the electrostatic potential of decalanine calculated using the PME 
method (blue indicates positive charge, while red indicates negative)34  
 
The power of this program is further increased by its multithread capabilities. 
NAMD possesses the ability to split its computational load into several parts, which can 
then be distributed over several processing units, or even a high-powered 
computational network34. This speeds up the process many times over and allows these 
large-scale simulations to be completed in a reasonable time frame.  
  
24 
 
 
Methods 
Once the models have been generated using the Rosetta suite, they must be 
modified somewhat to prepare them for simulations. From this point forward, the 
methods used to manipulate these two models are identical. The two models (Ca2+-
bound and apo forms) were first solvated by adding a box consisting of water molecules 
around the protein. This box was generated with edges 14 angstroms from the furthest 
atom on each side to allow for sufficient space for the periodic boundary conditions. The 
models are then ionized. A number of potassium and chloride ions are inserted into the 
water box. The number of ions gives a concentration approximately equal to cellular 
conditions. There are slightly fewer potassium ions contained in the calcium-bound 
model to account for the increased positive charge provided by the calcium. The 
resulting models contain ~20,000 atoms to be simulated between the protein itself, ions, 
and water molecules (Figure 6). 
 
 
Figure 6: An image of apo troponin C, fully solvated within a large water box, 
tilted slightly at an angle. 
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While the systems now contain all molecules necessary for simulation, they are 
not quite ready for the full simulation runs. The water molecules, randomly placed 
around the protein, have not formed the hydration shell around the macromolecule as 
they would in an actual cell. To achieve this, the simulation begins with a minimization 
step. This step allows for energy minimization of water molecules situated around the 
protein. 
 To maintain the protein structure during this step, during the first part of the 
simulation, the atoms of the protein are held in place using a restraint file, which is used 
by NAMD to restrict the movement of the protein chain while the water and ions form 
around it. This minimization step (min_1) is run at 0 K to eliminate the movement of 
water molecules that occurs under normal conditions so that only the energy 
minimization is considered. Simulations were carried out using CHARMM force field 
parameters37. The first minimization step is run for 10,000 steps, with each step lasting 
2 femtoseconds. Once this minimization step is completed, a second step is carried out 
for another 10,000 steps at 0 K, but without the restraint conditions. This allows for 
small minimization shifts in the protein in response to the formation of the water shell.  
 The system is now fully minimized, but still sits at 0 K. The system needs to run 
at 300 K to accurately simulate cellular conditions. To heat the system without 
significantly disturbing the contents, an equilibration step is necessary. This step pairs 
the cell with a simulated heat bath using Langevin dynamics38, which introduces heat 
into the system while also accounting for frictional forces experienced by the collision of 
solvent molecules. This step again utilizes a restraint file, but slowly lessens the amount 
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of restraint it utilizes to allow for a gradual equilibration process that maintains protein 
structure. By the end of the equilibration, the models are ready for the full simulation.  
 The full simulation was completed in 100 ns increments. The Langevin heat bath 
was maintained at 300 K, with a second control implemented to maintain pressure. This 
control used a slightly modified version of the Hoover method39, again using Langevin 
dynamics to control pressure fluctuations. The size of the cell is periodically adjusted to 
maintain an average pressure of 1.03125 bar (standard pressure at sea level). For this 
simulation, the timestep was set to 2 fs, meaning that the atoms moved for 2 
femtoseconds under their current equation of motion before the simulation was 
momentarily paused to allow for a recalculation of the various forces. Every 1000 
timesteps (2 picoseconds), the program saved a snapshot of the system, allowing for an 
accurate sampling of the various conformations that the protein experienced. The 
program also saves all information related to the velocity and position of the atoms in 
the system, allowing each subsequent run to begin where the previous one completed. 
8 increments were run for each system, resulting in a total of 800 ns of simulation, with 
40,000,000 frames saved for each.  
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Results: 
The 800 ns of simulations for each model yielded 40,000,000 frames contained in 8 dcd 
files. Using the visualization software VMD40, the partner program of NAMD, each of 
those frames was converted into its own separate PDB file, removing all waters and 
ions. This allows for analysis of the internal shifts of the protein conformation over time. 
Interhelical Angle Analysis 
It is difficult to quantify the “openness” of the hydrophobic patch to which TnI typically 
binds. To do so effectively, it is necessary to examine a certain interhelical angle. 
Experimental data shows that the angle between helices A (residues 14-27) and B 
(residues 37-46) varies greatly between “closed” and “open” conformations. Using a 
program known as interhlx [K. Yap, University of Toronto], these angles can be 
measured for each frame of the simulation 
Apo form 
         The apo form of skeletal troponin C, as expected, remained largely unchanged 
throughout the simulation. As seen in Figure 7, the interhelical angle that signified the 
exposure of the hydrophobic patch rarely wavered, never dipping to the fully open 90⁰ 
observed in experimental measurements of calcium-bound, open troponin C molecules 
(both skeletal and cardiac forms)30. In fact, the lowest angle experienced over the entire 
simulation was only 105⁰. This matches both expectations and previous experiments. 
Without the presence of calcium, it is expected that the troponin molecule would open 
incredibly rarely, if ever. If the protein were to open spontaneously, this would 
significantly affect the highly-controlled process of muscle contraction in humans. 
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Fig. 7: Interhelical angle of apo skeletal troponin C helices B and C over time. Note 
the relative stability, with most frames falling between 110⁰ and 150⁰. Compare to Fig. 
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Ca2+-bound form 
         Unlike the apo form, the calcium bound form was highly variable throughout the 
time of the simulation, as can be seen in Figure 8. The interhelical angle began in the 
“open” range. However, within a few nanoseconds, the protein closed up, quickly 
reaching the typical angle of the closed conformation (~130⁰). Based on previous 
computational results21, 22, this result was similar to cardiac troponin. This is somewhat 
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surprising given that calcium-bound models of skeletal troponin are found in a fully open 
state. While this similarity with cardiac troponin suggests that troponin C would remain 
open for incredibly short time fractions, the skeletal troponin seemed to settle in a much 
more open conformation, finding what seemed to be a separate equilibrium, perhaps 
due to an energy well of some sort, for a few nanoseconds. This more closely matches 
experimental results, but the shift was fairly temporary. Eventually, the protein once 
again reached a relatively closed conformation, with most angles falling between 100⁰ 
and 140⁰. However, the protein did shift to the fully open conformation twice more within 
the simulation time, with hundreds of nanoseconds between each opening event.  
 
Figure 8: Plot of the interhelical angle of helices A and B over time for calcium-bound 
skeletal troponin C. 
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Comparison and Analysis 
         While it is useful to visually examine the graphical representation of this opening 
event, the data can also be used quantitatively. By assigning a cutoff angle to indicate 
the split between open and closed conformations and treating these conformations as 
two distinct states of the protein, one can assume that the two separate energy states 
form a Boltzmann distribution based on the number of frames found in each state20. 
Using this assumption and the equation for a Boltzmann distribution of states (Figure 9), 
the energy difference between open and closed states can be quantified. The results of 
these calculations are shown in Figure 10 
ΔG = kT ln Nclosed / Nopen 
Figure 9: Calculation of energy difference utilizing the Boltzmann distribution 
equation20 
 
Based on this data, it is obvious why the open conformation was never observed 
for the apo form of TnC. A simple linear extrapolation of this curve would show the 
massive energy barrier that the system would need to overcome in order to shift the apo 
form to an open state.  
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Figure 10: Energy barrier using various interhelical angles as the cutoff between 
“open” and “closed” conformations, calculated using the Boltzmann distribution of 
states equation. 
For the calcium-bound form, this energy barrier is not nearly as insurmountable. 
Based on the traditional definition of open state as any protein with interhelical angle < 
90⁰, the energy barrier between the open and closed conformations of calcium-bound 
troponin is only 3.2 kcal/mole. While this barrier is still significant, as evidenced by the 
fact that the calcium-bound form still spends most of the simulation in a relatively closed 
conformation, it is not nearly as massive as that of the apo form. While the calcium-
bound form follows a relatively linear trend when comparing cutoff angle to energy 
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difference (R2=.90), its linearity is somewhat diminished by the apparent dip in the trend 
between 95 and 110. This is likely due to the previously-mentioned state of near-
stability for a few nanoseconds in the early parts of the simulation. 
         Similarly, this data can also be used to quantify the average time in between 
opening events by dividing the time spent in the open state by the number of times the 
transition between states occurred. The results of this calculation are shown in Figure 
11. When graphed on a logarithmic timescale, the results show a similar trend to that of 
the energy change. The time between opening events is inversely related to the cutoff 
angle in a somewhat linear fashion. For all angles that the apo form exhibited, the apo 
form spent a significantly greater time between opening events, and based on other 
data, it can be expected that this trend would continue. Once again, the aberration in 
the mostly linear-seeming trend line is likely due to the early fluctuation near the open 
conformation that occurred in the calcium-bound state. Using the standard cutoff angle 
of 90⁰, skeletal troponin C spent ~3 nanoseconds on average in the closed conformation 
in between opening events. This may seem like a relatively short time-scale, but two 
things should be noted. First, even a 3-nanosecond gap is significant compared to the 
length of time that the molecule spends in the closed conformation, which is often on 
the order of a few picoseconds. Second, this gap includes the short amount of time that 
the protein spent fluctuating just above the cutoff angle. Note the distance between the 
other two significant opening events, which have nearly 200 nanoseconds between 
them.  
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Figure 11: Average time in nanoseconds between opening events, based on different 
cutoff angles 
 
Based purely on examination of the interhelical angle plot, one may assume that 
the calcium-bound form possesses a more dynamic nature. This assumption can be 
quantified in a number of ways using VMD, which can calculate the root mean square 
deviation (RMSD) of the various atoms within the protein. Using this information, a 
numerical value can be assigned to the level of fluctuation from the starting point across 
time, as shown in Figure 12. It is clear from this information that after an initial 
stabilization, the apo form remains relatively unchanged, with few major differences in 
its structure. The calcium-bound form, on the other hand, is demonstrably less stable, 
with a number of major spikes in RMSD, indicating a significant shift in protein structure. 
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There is clearly a significant increase in the dynamic nature of the protein upon the 
binding of calcium, based on this evidence.  
 
Fig. 12: Side-by-side comparisons of RMSD over time for both apo (L) and calcium-
bound (R) states 
 
While this evidence of increased fluctuation is useful, even protein subunits as 
small as troponin C are too large to have their behavior fully defined using a single 
value. VMD allows for another useful feature in its ability to calculate the RMSF, or root-
mean-square fluctuation, which measures exactly how much each atom varies across 
the entire simulation. By measuring the alpha carbons of each amino acid, this 
measurement can provide an accurate picture of exactly which residues provide much 
of the variability in the structure. Comparing the two forms in Figure 13, it is clear that 
the residues share similar properties regardless of the presence of calcium. However, it 
is important to note the significant differences, particularly the difference in fluctuation 
between residues 20 and 50, which also contains the two helices that are of significant 
interest to this project. This provides further evidence in support of the idea that the 
binding of calcium induces a shift in the dynamics of the protein, causing it to become 
more variable in its structure. The spike in fluctuation between residues 60 and 70 is 
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also notable, but there is little indication that this portion of the protein has significant 
relevance in the hydrophobic patch opening event22. 
 
 
Figure 13: RMSF values for amino acids for both protein forms. Note the 
higher values present for the Ca2+-bound form in the relevant regions indicating the 
second (B) helix and the loop between helices A and B 
(28-36, 37-46) 
 
Discussion 
 Based on this data, it seems that calcium binding does not induce a direct 
conformational change that allows for exposure of the hydrophobic site of troponin C, 
but rather an increase in the variability of the structure. The energy barrier that the 
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protein must surmount in order to open is nearly insurmountable without calcium, and 
even with the calcium binding, it is still significant, on the order of 3-4 kcal per mole. 
Without TnI to stabilize the open structure, evidence suggests that even the calcium-
bound version would spend much of its time in the closed conformation. This obviously 
does not agree with experimental NMR data, which shows skeletal troponin C in a fully 
open conformation when calcium is present. This computational data should not be 
taken as conclusive, especially in light of this conflict with experimental evidence, but it 
is certainly significant to note the significant energy difference between the two forms.  
 The increased dynamic nature of calcium-bound skeletal troponin C is also 
clearly evidenced in this simulation. Increased variability, particularly between the A and 
B helices of the molecule, is shown by the significant differences in the RMSD and 
RMSF values shown in these simulations. The calcium-bound form obviously samples a 
far greater number of conformations in the relevant EF had domain over time due to the 
decreased structural stability, and this sampling clearly trends towards the more open 
conformations, but the protein never fully settles into an open state. It instead remains 
highly variable throughout the life of the simulation. It is possible that the presence of 
TnI in vivo stabilizes the open structure through an induced fit mechanism, wherein the 
increased variability allows TnC to reach a state to which TnI can begin to bind, and this 
binding further stabilizes the most open conformation, leading to a more static open 
structure, but that is beyond the scope of this particular project. 
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Chapter 4: 
Future Directions 
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 These results lend themselves to a number of further questions. First and 
foremost is the disagreement between the results that show the closing of the 
hydrophobic pocket in skeletal troponin and the experimentally-determined structures. 
While the available NMR data suggests that the hydrophobic pocket remains open with 
relative consistency30, this computational study shows a significant energy barrier that 
causes the protein to remain in a closed conformation for more than 99% of the time. It 
is worth investigating the reasons behind this discrepancy. Perhaps there is some 
interaction for which computational simulations fail to account. There are a number of 
approximations utilized to allow for simulation on a reasonable time-scale in NAMD34, 
and it is possible that because of these methods, the integration of the equations of 
motion for these molecules does not include an interaction that stabilizes the open 
conformation of the molecule. It is even possible that peculiarities in the procedure used 
to clone and analyze the proteins structure led to conditions that altered the stability of 
the open conformation. This possibility has been proposed by Gallagher et. al. for 
structures determined via crystallography, where crystallization procedures led to 
possible stabilization of certain structures that did not completely agree with 
experimentation41, but a possible mechanism for a similar discrepancy in NMR analysis 
is not known.  
 Regardless of the cause, it is clear that a difference does exist between this 
computational study and in vitro structural studies, and this discrepancy is an obvious 
avenue for further investigation. 
 Recent computational studies of troponin C have examined it in isolation. While 
this is generally more convenient, and can still give significant insight into the various 
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properties of the protein, it does not accurately represent the relevant interactions that 
take place within muscle fibers, particularly interactions with the TnI peptide. Studies by 
Lindert et al. and Genchev et al. have utilized some systems containing multiple 
components of the troponin system21, 22, but computational studies of the protein-protein 
interactions remain relatively unexplored. Given the ever-increasing power of 
computation, research into these complex protein-protein interactions could take place 
in the near future. 
 Additionally, given the power of the Rosetta CM, it is theoretically possible to 
create models of mutations of the troponin protein. Given the number of studies that 
show the effects of various mutations on the activity and function of troponin13-15, 
investigation of these mutations using computational methods would be a worthwhile 
avenue of study. If computational results continue to disagree with experimental trials as 
this investigation seemed to do, it could provide further insight into possible flaws in 
utilizing these numerical approximations of real-life physics in this particular context.   
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